MTOR and cervical carcinoma: Our cellular experiments showed that naringenin can inhibit the proliferation, migration, and invasion of cervical cancer cells, and further western blot confirmed that naringenin achieves these effects by EGFR/PI3K/AKT/mTOR pathway.